首页> 外文期刊>Oncology reports >Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation
【24h】

Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation

机译:四月击倒与jiedu小洋尹,中国药用食谱的协同效应,抑制肝细胞癌细胞增殖

获取原文
获取原文并翻译 | 示例
           

摘要

It is well documented that A proliferation-inducing ligand (APRIL), a member of the tumor necrosis factor super family, plays a crucial role in the occurrence and development of tumors. In the present study, we evaluated the synergistic effect of APRIL knockdown and Jiedu Xiaozheng Yin (JXY), a Traditional Chinese Medicinal recipe, on the inhibition of hepatocellular carcinoma (HCC) cell proliferation and elucidated the underlying mechanism. The results demonstrated that both APRIL knockdown using small interfering RNA (siRNA) and JXY treatment could trigger cell cycle arrest and cell apoptosis, and suppress HCC cell proliferation through an NF-kappa B-related pathway. Synergism was further demonstrated between APRIL knockdown and JXY treatment. In conclusion, these results indicate that APRIL is a target gene for HCC and combination of siRNA-APRIL and JXY application holds great promise as a novel approach for the treatment of APRIL-positive HCC.
机译:有很好的记录结果,诱导诱导的配体(四月),肿瘤坏死因子超级家庭的成员在肿瘤的发生和发展中起着至关重要的作用。 在本研究中,我们评估了4月敲低的协同效应和jiedu小洋尹(jxy),中药配方,抑制肝细胞癌(HCC)细胞增殖并阐明了潜在机制。 结果表明,使用小干扰RNA(siRNA)和JXY治疗的4月敲低可以触发细胞周期骤停和细胞凋亡,并通过NF-Kappa B相关途径抑制HCC细胞增殖。 四月敲低和JXY治疗之间进一步证明了协同作用。 总之,这些结果表明,4月是HCC的目标基因,SiRNA-April和JXY申请的组合具有巨大的希望作为治疗4月阳性HCC的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号